ScoreWhy is Astec Lifesciences Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.40 times
- The company has been able to generate a Return on Equity (avg) of 7.84% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 6 consecutive quarters
- OPERATING CF(Y) Lowest at Rs -8.40 Cr
- NET SALES(Q) At Rs 73.72 cr has Fallen at -25.20%
- DPR(Y) Lowest at 0.00%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -24.15%, its profits have fallen by -10%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -24.15% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pesticides & Agrochemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Astec Lifescienc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Astec Lifescienc
-38.99%
-0.42
57.48%
Sensex
8.49%
0.43
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.21%
EBIT Growth (5y)
-189.76%
EBIT to Interest (avg)
2.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.76
Tax Ratio
0.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.21%
ROCE (avg)
3.10%
ROE (avg)
7.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
28
Price to Book Value
3.19
EV to EBIT
-31.74
EV to EBITDA
-205.71
EV to Capital Employed
2.18
EV to Sales
4.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.14%
ROE (Latest)
-27.53%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 0.56 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.89 times
NET SALES(Q)
Highest at Rs 124.72 cr
PBT LESS OI(Q)
Highest at Rs -14.41 cr.
PAT(Q)
Highest at Rs -13.61 cr.
EPS(Q)
Highest at Rs -7.05
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Astec Lifescienc
Operating Profit to Interest - Quarterly
Highest at 0.56 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 124.72 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 124.72 cr has Grown at 32.88%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs -14.41 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs -13.61 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs -7.05
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 0.89 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
